证券代码：002305 证券简称：*ST 南置 公告编号：2025-045 号 南国置业股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假记载、误导 性陈述或者重大遗漏。 一、股票交易异常波动的情况介绍 南国置业股份有限公司(以下简称"公司")连续 3 个交易日（8 月 19 日、8 月 20 日、8 月 21 日）收盘价格跌幅偏离值累计超过 12%，根据《深圳证券交易所交易规则》 的相关规定，属于股票交易异常波动。 二、对重要问题的关注、核实情况说明 的资产范围、交易价格等要素均未最终确定，交易双方尚未签署任何协议，交易方案 仍需进一步论证和沟通协商，并履行必要的决策和审批程序，交易尚存在重大不确定 性。公司将根据交易的进展情况，分阶段及时履行信息披露义务，敬请广大投资者注 意投资风险。 券交易所股票上市规则》的相关规定，公司股票交易已被实施"退市风险警示"；同时， 鉴于公司最近三个会计年度扣除非经常性损益前后净利润孰低者均为负值，且 2024 年 度审计报告显示公司持续经营能力存在不确定性，根据《深圳证券交易所股票上市规 则》的相关规定，公司股票交易被叠加实施"其他风险警示"。 ...

Core Viewpoint - The stock of Jinhua Chunguang Rubber and Plastic Technology Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from August 18 to August 20, 2025 [1][2][3] Group 1: Stock Trading Abnormality - The company's stock price increased by more than 20% cumulatively over three consecutive trading days, which is classified as an abnormal trading fluctuation according to the Shanghai Stock Exchange rules [1][2] - The company conducted a self-examination and confirmed that there are no undisclosed significant matters or important information affecting the stock price [2][3] Group 2: Operational and Major Events - The company's daily operations and external environment have not undergone significant changes [2] - There are no major undisclosed events such as asset restructuring, share issuance, or significant business cooperation that could impact the stock price [2] Group 3: Media and Market Sentiment - The company did not find any media reports or market rumors that could significantly affect the stock price [2] - No sensitive information that could impact the stock price was identified during the verification process [2] Group 4: Board Statement - The board of directors confirmed that there are no undisclosed matters or related plans that should be disclosed according to the stock exchange rules [3] - The board also stated that previous disclosures do not require correction or supplementation [3]

Core Viewpoint - The stock of Chengdu Olin Biological Technology Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days from August 18 to August 20, 2025, prompting the company to conduct a self-examination and confirm the normality of its business operations [1][3][4]. Group 1: Business Operations - The company confirmed that its daily operations are normal, with no significant changes or fluctuations in production costs and sales [1][2][3]. - The company is actively progressing in product research, production, and sales, with no major adjustments in the market environment or industry policies [1][2]. Group 2: Major Events - As of the announcement date, the company reported no undisclosed significant information or ongoing major asset restructuring, share issuance, or other substantial events [2][3]. - The company has not identified any media reports or market rumors that could significantly impact its stock price [2][3]. Group 3: Stock Performance - The closing price of the company's stock on August 20, 2025, was 33.11 yuan per share, with a significant price increase compared to most peers in the industry and the Shanghai Composite Index [3][5]. - The company's rolling price-to-earnings (P/E) ratio is 338.72, which is significantly higher than the industry average P/E ratio of 32.11, indicating a potential short-term market overheating risk [3][5].

证券代码：603221 证券简称：爱丽家居 公告编号：临 2025-033 爱丽家居科技股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 重要内容提示： ?爱丽家居科技股份有限公司（以下简称"公司"）股票于 值累计达 20%，根据《上海证券交易所交易规则》的有关规定， 属于股票交易异常波动情形。 ?公司目前生产经营活动正常，经公司自查，并向实际控制 人及控股股东核实，截至本公告披露日，不存在涉及公司应披露 而未披露的重大资产重组、股份发行、收购、债务重组等重大信 息。 ?公司敬请广大投资者注意二级市场投资风险，理性决策， 审慎投资。 一、股票交易异常波动的具体情况 公司股票于2025年8月19日、8月20日连续两个交易日收盘价 格跌幅偏离值累计达20%，根据《上海证券交易所交易规则》的 有关规定，属于股票交易异常波动情形。 二、公司关注并核实的相关情况 针对公司股票交易异常波动的情况，公司对有关事项进行了 核查，并发函问询了实际控制人和主要股东，现将有关情况说明 如下： （一） 生产经营情况 ...

华丽家族股份有限公司 股票交易异常波动公告 证券代码：600503 证券简称：华丽家族 公告编号：临2025－025 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 华丽家族股份有限公司（以下简称"公司"）股票于2025年8月19日、2025 年8月20日连续二个交易日内收盘价格涨幅偏离值累计超过20%。根据《上海证 券交易所交易规则》的有关规定：股票连续三个交易日内收盘价格涨幅偏离值累 计超过20%，属于股票交易异常波动。 ? 经公司自查，并向控股股东、实际控制人核实，截至本公告披露日，除公 司已披露事项外，不存在其他应披露而未披露的重大信息。 ? 敬请广大投资者注意二级市场交易风险，理性决策，审慎投资。 一、股票交易异常波动的具体情况 公司股票于2025年8月19日、2025年8月20日连续二个交易日内收盘价格涨幅 偏离值累计超过20%。根据《上海证券交易所交易规则》的有关规定：股票连续 三个交易日内收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动。 二、公司关注并核实的相关情况 针对公司股票交易 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：002600 证券简称：领益智造 公告编号：2025-112 债券代码：127107 债券简称：领益转债 广东领益智造股份有限公司 一、股票交易异常波动的情况介绍 广东领益智造股份有限公司（以下简称"公司"）股票于 2025 年 8 月 18 日、 超过 20%，根据深圳证券交易所的有关规定，属于股票交易异常波动情形。 二、公司关注并核实情况的说明 针对公司股票异常波动，公司进行了自查，并对相关事项进行了核查，现将 有关情况说明如下： 大影响的未公开重大信息； （公告编号：2025-089）， （www.cninfo.com.cn）上披露了《2025 年半年度业绩预告》 经公司财务部门初步测算，2025 年半年度公司归属于上市公司股东的净利润为 盈利 90,000 万元–114,000 万元，比上年同期增长 31.57%–66.66%，扣除股权 激励摊销费用归属于上市公司股东的净利润为盈利 104,000 万元–128,000 万元， 比上年同期增长 48.59%–82.88%，扣除非经常性损益后的净利 ...

Core Viewpoint - The stock of Huayi Family Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price deviation exceeding 20% over two consecutive trading days on August 19 and 20, 2025 [2][4]. Group 1: Stock Trading Abnormality - The stock price deviation of Huayi Family Co., Ltd. exceeded 20% over two consecutive trading days, which is significant under the Shanghai Stock Exchange trading rules [2][4]. - If the stock price deviation exceeds 20% for three consecutive trading days, it will be classified as an abnormal trading fluctuation [4]. Group 2: Company Verification and Operations - The company conducted a self-examination and confirmed that its production and operations are normal, with no significant changes in the internal and external environment [5]. - There are no undisclosed major operational information or events that could impact the stock price, including major asset restructuring or significant transactions [6]. Group 3: Media Reports and Market Rumors - Aside from the announcement regarding cash injection into Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. on August 11, 2025, no other media reports or market rumors have been identified that could significantly affect the stock price [7]. Group 4: Shareholding and Pledge Information - As of the announcement date, the controlling shareholder, Shanghai Nanjing (Group) Co., Ltd., holds 114,020,000 shares, accounting for 7.12% of the total share capital, with 90,075,800 shares pledged, representing 5.62% of the total share capital [10]. Group 5: Financial Performance - The company expects a net loss attributable to shareholders of the parent company in the range of -12.5 million to -8.35 million yuan for the first half of 2025, indicating a shift from profit to loss compared to the previous year [11].

Core Viewpoint - Chengdu Olin Biological Technology Co., Ltd. experienced a significant stock price fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days from August 18 to August 20, 2025, indicating abnormal trading activity [2][3]. Group 1: Stock Trading Abnormalities - The company's stock price closed at 33.11 yuan per share as of August 20, 2025, with a recent cumulative increase that surpasses most peers in the industry and the Shanghai Composite Index [2][9]. - The rolling price-to-earnings (P/E) ratio for the company is reported at 338.72, significantly deviating from the industry average P/E ratio of 32.11 for the pharmaceutical manufacturing sector [2][9]. Group 2: Company Operations and Confirmations - The company conducted a self-examination and confirmed that its daily operations remain normal, with no significant changes or major events affecting its business [4][5]. - There are no undisclosed significant matters or ongoing major asset restructuring, share issuance, or other substantial corporate actions as of the announcement date [5][8]. Group 3: Market and Media Influence - The company has not identified any media reports or market rumors that could have significantly impacted its stock price, nor any leaks of undisclosed major information by company personnel [6][7].

Core Viewpoint - The stock of Taihao Technology Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase of 20% over three consecutive trading days from August 18 to August 20, 2025, which is classified as an abnormal trading situation according to the Shanghai Stock Exchange rules [2][4]. Group 1: Stock Trading Abnormality - The stock price deviation reached a cumulative increase of 20% over three consecutive trading days [2][4]. - The company confirmed that its main business and production operations are normal, with no significant changes in market conditions or industry policies [2][5]. Group 2: Company Verification and Major Events - The company is planning to acquire a 27.46% stake in its subsidiary, Taihao Military Industry, through a share issuance [3][7]. - The first major shareholder, Tongfang Co., Ltd., confirmed that there are no undisclosed significant matters related to the company [7][12]. Group 3: Media Reports and Market Rumors - The company has not identified any media reports or market rumors that could significantly impact its stock price [8][9]. Group 4: Board of Directors Statement - The board of directors confirmed that there are no undisclosed matters that should be disclosed according to the relevant regulations of the Shanghai Stock Exchange [12].

Core Viewpoint - The company, Yazhen Home Co., Ltd., has experienced a significant stock price fluctuation, leading to a temporary suspension of trading to protect investor interests. The stock will resume trading on August 21, 2025, after a thorough review of its trading activities and financial performance [2][3][13]. Group 1: Stock Trading and Suspension - The company's stock price increased by 33.92% from July 30 to August 6, 2025, significantly deviating from the Shanghai Composite Index and the furniture manufacturing industry [2][3]. - The stock was suspended from trading on August 7, 2025, for a period not exceeding 10 trading days, to conduct a review of the trading situation [3][13]. - The stock will resume trading on August 21, 2025, following the completion of the review [3][13]. Group 2: Financial Performance - For the fiscal year 2024, the company reported total revenue of 202.40 million yuan, with a net loss attributable to shareholders of 116.96 million yuan [4][9]. - The company expects a net loss for the first half of 2025 to be between 39.50 million yuan and 33.00 million yuan [4][9]. - The company has been placed under delisting risk warning since May 6, 2025, due to its financial performance [4][9]. Group 3: Acquisition and Business Development - The company plans to acquire 51% of Guangxi Zirconium Industry Technology Co., Ltd. from Hainan Zirconium Titanium Resources Holdings Group Co., Ltd. for 55.45 million yuan [5][15]. - As of August 20, 2025, the acquisition has been completed, and Guangxi Zirconium has become a subsidiary of the company [5][16]. - The company has initiated the pledge procedures for the acquired shares, which have been successfully registered [18].